We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Hit Again With Antitrust Charges

Law360 (March 1, 2006, 12:00 AM EST) -- A government service cooperative has charged AstraZeneca with violating U.S. competition law, the latest swipe in a string of suits filed by nearly a dozen unions, pension funds and government agencies accusing the pharmaceutical giant of illegally trying to prevent generic versions of its blockbuster heart drug, Toprol-XL, from entering the marketplace.

The National Joint Powers Association, a self-funded cooperative which supplies goods and services to government agencies, says that Anglo-Swedish AstraZeneca’s illegal monopolization and attempt to monopolize the market for Toprol-XL and its generic versions...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.